Home Beauty Health A new gene therapy appears to serve as a functional cure for the most common type of hemophilia, with patients who received the one-time IV therapy with more than 90% decrease in bleeding events 2 to 3 years after treatment, reports the early clinical trial in the New England Journal of Medicine.

on January 02, 2020
A new gene therapy appears to serve as a functional cure for the most common type of hemophilia, with patients who received the one-time IV therapy with more than 90% decrease in bleeding events 2 to 3 years after treatment, reports the early clinical trial in the New England Journal of Medicine. submitted by /u/mvea
[link] [comments]


from Health https://ift.tt/39CLbfJ
,
Share To:

Unknown

View Profile

Post A Comment:

0 comments so far,add yours

Subscribe to: Post Comments (Atom)